AP001

WHOPAR

Part 1

Part 2

Part 5

Part 7

Product name

Caffeine citrate

Dosage

10mg/ml - Solution, Oral

Laboratory

Macarthys Laboratories Limited

United Kingdom of Great Britain and Northern Ireland

Part 1 - Abstract
Part 2 - All accepted presentations (including photo)
Part 3 - Patient information leaflet, as approved by the reference authority¹
Part 4 - Summary of product characteristics, as approved by the reference authority¹
Part 5 - Labelling, as approved by the reference authority¹
Part 6 - Scientific discussion³
Part 7 - Steps before Prequalification
Part 8 - Steps following marketing authorisation³

¹ If the SRA approved PIL, SmPC and/or labelling, or equivalents thereof, are available in English on the reference SRA website, a link is included in the WHOPAR part 1. If not, the documents are included, if necessary, as certified English translation.
³ These parts are not available for all products prequalified via the abridged route. If a public assessment report is available and contains this information, a weblink is included in part 1.

Overview of WHO Public Assessment Report (WHOPAR)